and dr. uhl as the head of obg, those doctors are in the process of being trained. and over the last couple of months, if you look at the total data of actions being taken on generic applications has gone up. that's a positive trend. is it at the level where, you know, we can look out at the short-term and say we think the backlog is going to go away any time soon? probably not, but there are positive trend lines we have to capitalize on and focus as much on the areas of alignment as we are or if not more so than on the areas where there are things we still have to work through. >> all right. to this point, we have lots of strategies here to consider as we move forward in this area. we do, once again, want to open it up to questions from all of you. so once more, please come to the center aisle and avail yourselves of the microphone. go ahead. >> ilene wood, chief pharmacy officer for capital districts physician health plan in albany, new york. great panel. i wish i could ask you all a question. but i have to go to the hot seat to miss shaw. it's obvious, you know,